Results 141 to 150 of about 612,705 (204)

Gastrointestinal eosinophilic sclerosing fibroplasia and concurrent segmental T‐cell lymphoma in a cat

open access: yesVeterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Abstract A domestic shorthair cat was presented with lethargy and inappetence. Abdominal ultrasound revealed a large jejunal mural mass with diffuse wall thickening without loss of wall layering, severe jejunal lymphadenopathy, and moderate peritoneal effusion.
Riley Aronson   +4 more
wiley   +1 more source

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

open access: yesArthritis Care &Research, Volume 78, Issue 10, Page 1449-1466, October 2026.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci   +25 more
wiley   +1 more source

[Effect study of Sonic hedgehog overexpressed hair follicle stem cells in hair follicle regeneration]. [PDF]

open access: yesZhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2023
Yang Y, Wang G, Yang Q, Diao B.
europepmc   +1 more source

From Marginal to Central: Marginal Zone‐like B Cells as Critical Targets in Cladribine‐Treated Multiple Sclerosis

open access: yesAnnals of Neurology, Volume 100, Issue 4, Page 808-823, October 2026.
Objective Multiple sclerosis (MS) is a chronic autoimmune disease where B cells play a central pathogenic role. Cladribine, an oral therapy, provides durable benefits by reshaping lymphocyte populations, yet its specific long‐term impact on distinct B‐cell subsets is not fully understood.
Marta Pirronello   +20 more
wiley   +1 more source

Investigation Into the Metabolism and Elimination Behavior of RU 58841, and Its Influence on the Steroid Profile in Humans

open access: yesBiomedical Chromatography, Volume 40, Issue 10, October 2026.
ABSTRACT RU 58841 is a nonsteroidal antiandrogen, developed for the treatment of androgen‐dependent conditions. This study aimed to characterize the human metabolism of RU 58841 for the first time and to assess its systemic exposure following topical administration.
Aylin Okutan   +4 more
wiley   +1 more source

Biosome Therapy for Androgenetic Alopecia in a Patient With Incomplete Response to Minoxidil and Finasteride: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT A 25‐year‐old man with androgenetic alopecia showed limited response to long‐term minoxidil and finasteride. Three monthly Biosome treatment sessions were associated with progressive clinical improvement in apparent hair coverage on serial follow‐up photographs, without treatment‐related adverse events during the 3‐month observation period ...
Mohammed Almashali
wiley   +1 more source

Home - About - Disclaimer - Privacy